BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38047239)

  • 1. Vitamin D receptor expression in hydatidiform mole and gestational trophoblastic neoplasia: A cross-sectional study.
    Sasotya RS; Kustiandi A; Hidayat YM; Effendi JS; Permadi W; Harsono AB; Mulyantari AI; Hernowo BS
    J Taibah Univ Med Sci; 2024 Feb; 19(1):184-189. PubMed ID: 38047239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: a simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up or subsequent treatment.
    Uberti EM; Fajardo Mdo C; da Cunha AG; Rosa MW; Ayub AC; Graudenz Mda S; Schmid H
    Gynecol Oncol; 2009 Aug; 114(2):299-305. PubMed ID: 19427681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presentation, medical complications and development of gestational trophoblastic neoplasia of hydatidiform mole after intracytoplasmic sperm injection as compared to hydatidiform mole after spontaneous conception - a retrospective cohort study and literature review.
    Braga A; Andrade T; do Carmo Borges de Souza M; Campos V; Freitas F; Maestá I; Sun SY; Pedrotti LG; Bessel M; Junior JA; Filho JR; Elias KM; Horowitz NS; Berkowitz RS
    Gynecol Oncol; 2023 Mar; 170():179-185. PubMed ID: 36706644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study.
    Yamamoto E; Trinh TD; Sekiya Y; Tamakoshi K; Nguyen XP; Nishino K; Niimi K; Kotani T; Kajiyama H; Shibata K; Le QT; Kikkawa F
    Nagoya J Med Sci; 2020 May; 82(2):183-191. PubMed ID: 32581399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type.
    Schmitt C; Doret M; Massardier J; Hajri T; Schott AM; Raudrant D; Golfier F
    Gynecol Oncol; 2013 Jul; 130(1):86-9. PubMed ID: 23523617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose actinomycin D: Efficacy in the prophylaxis of postmolar gestational trophoblastic neoplasia in adolescents with high-risk hydatidiform mole.
    Uberti EM; Diestel MC; Guimarães FE; De Nápoli G; Schmid H
    Gynecol Oncol; 2006 Aug; 102(2):325-32. PubMed ID: 16476471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.
    Dantas PR; Maestá I; Cortés-Charry R; Growdon WB; Braga A; Rudge MV; Berkowitz RS
    J Reprod Med; 2012; 57(7-8):305-9. PubMed ID: 22838246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.
    Wang Q; Fu J; Hu L; Fang F; Xie L; Chen H; He F; Wu T; Lawrie TA
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD007289. PubMed ID: 28892119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Her-2/neu expression in hydatidiform moles for prediction of subsequent gestational trophoblastic neoplasia.
    Menczer J; Schreiber L; Berger E; Golan A; Levy T
    Gynecol Oncol; 2007 Mar; 104(3):675-9. PubMed ID: 17126893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiologic study on gestational trophoblastic diseases in Japan.
    Yamamoto E; Nishino K; Niimi K; Ino K
    J Gynecol Oncol; 2022 Nov; 33(6):e72. PubMed ID: 36047375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.
    Fu J; Fang F; Xie L; Chen H; He F; Wu T; Hu L; Lawrie TA
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD007289. PubMed ID: 23076934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The expression of EMT associated protein CK-18 and vimentin in gestational trophoblastic disease ].
    Cai Y; Xue Y; An RF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 45(6):960-3, 1014. PubMed ID: 25571724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of previous cesarean section (C/S) on the risk for post-molar gestational trophoblastic neoplasia (GTN).
    Cho HW; Ouh YT; Min KJ; Lee NW; Lee S; Song JY; Hong JH; Lee JK
    Gynecol Oncol; 2020 Mar; 156(3):606-610. PubMed ID: 31954533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review on management of gestational trophoblastic neoplasia.
    Sharami SRY; Saffarieh E
    J Family Med Prim Care; 2020 Mar; 9(3):1287-1295. PubMed ID: 32509606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia?
    Sun SY; Melamed A; Goldstein DP; Bernstein MR; Horowitz NS; Moron AF; Maestá I; Braga A; Berkowitz RS
    Gynecol Oncol; 2015 Jul; 138(1):46-9. PubMed ID: 25969351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of prostate stem cell antigen is associated with gestational trophoblastic neoplasia.
    Feng HC; Tsao SW; Ngan HY; Xue WC; Kwan HS; Siu MK; Liao XY; Wong E; Cheung AN
    Histopathology; 2008 Jan; 52(2):167-74. PubMed ID: 18184265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a routine second curettage for hydatidiform mole: a cohort study.
    Yamamoto E; Nishino K; Niimi K; Watanabe E; Oda Y; Ino K; Kikkawa F
    Int J Clin Oncol; 2020 Jun; 25(6):1178-1186. PubMed ID: 32144509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN and MDM2 expression in the prediction of postmolar gestational trophoblastic neoplasia.
    Lertkhachonsuk R; Tantbirojn P; Paiwattananupant K
    J Reprod Med; 2012; 57(7-8):333-40. PubMed ID: 22838251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of insulin-like growth factor binding protein 1 and ferritin light polypeptide in gestational trophoblastic neoplasia: combined cDNA suppression subtractive hybridization and microarray study.
    Feng HC; Tsao SW; Ngan HY; Xue WC; Chiu PM; Cheung AN
    Cancer; 2005 Dec; 104(11):2409-16. PubMed ID: 16222695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.